Somryst
510(k) K191716
Somryst is a medical device (FDA Class II; FDA product code QVO, Computerized Behavioral Therapy Device For Insomnia) made by Pear Therapeutics, Inc., cleared under FDA 510(k) K191716 on 23 Mar 2020, active as of 22 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK191716 | Date23 Mar 2020 | StatusActive |
Official records
- FDA 510(k) database K191716
From the FDA record
- Received by the FDA
- 26 Jun 2019
- FDA decision
- 23 Mar 2020 (Substantially Equivalent)
- FDA review time
- 271 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- QVO
- Device class
- Class II
- Regulation
- 21 CFR Part 882.5801
- Advisory committee
- Neurology
- FDA decision
- SESE Substantially Equivalent
Devices cleared under K191716
Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.
| UDI-DI | Size and differences | |||
|---|---|---|---|---|
| Somryst | 651010 / SOMRYST | 15694311112112 | — | On the market |
| Somryst™ 1 | 1 | 10851580008255 | — | On the market |